- DEPARTMENT OF ELECTRICITY AND ENERGY PARTICIPATES AT THE 2026 AFRICA ENERGY INDABA AS THE OFFICAL GOVERNMENT HOST
- The BRVM Investment Days 2026
- Leadership at the Centre of Africa’s Investment Story
- Delisting and take-private trend is a sign of progress rather than crisis for South Africa
- Energy: The Cornerstone of Africa's Infrastructure Development
Novartis Speeds New Anti-Malarial as Older Drug Loses Potency
LAGOS (Capital Markets in Africa) – Novartis AG began testing a new anti-malaria pill in Africa, advancing development of an alternative to its most effective treatment that billionaire philanthropist Bill Gates said risked losing potency. Patients in Mali infected with the mosquito-borne parasite began receiving the experimental drug, known as KAF156, in combination with another medicine, the drugmaker said Monday. More than 500 children and adults across nine countries in Africa and Asia will be enrolled in the mid-stage study…
Read More






